Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
about
Genomic and non-genomic effects of glucocorticoids: implications for breast cancerInteractions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes.Genetic, functional and molecular features of glucocorticoid receptor bindingGlucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy.Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan.Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancerTransforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells.Targeting the glucocorticoid receptor in breast and prostate cancers.11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal TumorigenesisTissue-specific glucocorticoid action: a family affair.Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation.Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer.Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.The Non-Conventional Effects of Glucocorticoids in Cancer.Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.The Marine Natural Product Pseudopterosin Blocks Cytokine Release of Triple-Negative Breast Cancer and Monocytic Leukemia Cells by Inhibiting NF-κB Signaling.Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB.Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.Why glucocorticosteroids should remain in the list of prohibited substances: a sports medicine viewpoint.The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.Fenofibrate prevents skeletal muscle loss in mice with lung cancer.A novel computational approach for drug repurposing using systems biology.Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancerPseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha
P2860
Q26851382-93195E26-481A-47E0-BC4D-4C7E29ED65C7Q33959230-5C0C5474-A6F7-4429-91AE-1BADC92E6D96Q34700511-2C66F2D5-4334-4BAD-8560-0C5645261D6DQ35566902-86D77504-4FB8-4E3B-9C80-DE3A2FB39E04Q35604651-99D7FCDE-29F2-4D60-8D10-4D69FE10F8C3Q35666129-2708B0B2-D9DE-432C-BBA0-1AB5D72E164EQ36050483-D3E188A9-73B3-493B-ACB2-B07FD1BFA20CQ36110492-3B7C854D-58C0-4C81-A155-E5756C9299ACQ36113549-588BCE1B-39BD-4309-BF4F-6A9F173C5AC1Q36729300-50D0986D-1A34-4D63-818C-A5930F73741FQ37078077-C0519735-A6F5-4E94-9570-16D3F5E415D8Q37274908-D85948A4-73AB-4D50-B82E-F1AE2CC19906Q37433415-C4611EBA-71E5-48F3-9CF4-36891DEB39C7Q37699154-D0B08DC2-FD14-487D-A26D-65BCE272F085Q38739362-38807193-8385-4BD5-B1FD-397C3238318BQ38817816-5E47F6AC-A696-4C49-8D51-196104DC0993Q39737357-5FF1F64D-A791-4694-97C9-EFB392C82E16Q41662036-02F0DED6-3B8E-4534-BAC8-A51F7362FEC8Q41964836-5CD97D22-9799-4E30-B5DA-2B5147172056Q42001077-E1300E06-7351-4004-82E6-E0A910EB6CF3Q42494555-6DA0EB35-4BFA-441A-9ED0-36EE6F510775Q43545244-AD8FE953-55C2-4C9C-A284-9A139B211C1DQ47898535-ECB718DF-93A7-4BF3-87C8-A0C80C669A48Q48291586-26143B55-0151-40E1-8825-B6E1C1BCDDCCQ48546803-F12AD8C4-07E5-4208-BA46-A915735ADB39Q52657953-2174D547-B117-492E-9F85-1EDFB4CDEA03Q57106904-F2D0BF55-A4D5-45FF-8318-4571F08AB22CQ58693175-DF921189-DCC1-4BD6-93E0-4403A0113F60
P2860
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@ast
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@en
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@nl
type
label
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@ast
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@en
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@nl
prefLabel
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@ast
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@en
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@nl
P2860
P31
P921
P356
P1433
P1476
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.
@en
P2093
Bruce D Keith
P2860
P2888
P356
10.1186/1471-2407-8-84
P407
P5008
P577
2008-03-28T00:00:00Z
P5875
P6179
1052520491